Thromb Haemost 2013; 110(01): 197-199
DOI: 10.1160/TH13-02-0112
Letters to the Editor
Schattauer GmbH

Non-O blood group as a risk factor for cerebral vein thrombosis

Antonella Tufano
1   Regional Reference Center for Coagulation Disorders, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy
,
Antonio Coppola
1   Regional Reference Center for Coagulation Disorders, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy
,
Assunta Nardo
1   Regional Reference Center for Coagulation Disorders, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy
,
Carlo Bonfanti
2   Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantova, Italy
,
Silvia Crestani
2   Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantova, Italy
,
Anna Maria Cerbone
1   Regional Reference Center for Coagulation Disorders, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy
,
Massimo Franchini
2   Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantova, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 09. Februar 2013

Accepted after minor revision: 21. März 2013

Publikationsdatum:
30. November 2017 (online)

 

 
  • References

  • 1 Stam J. Thrombosis of the cerebral vein and sinuses. N Eng J Med 2005; 352: 1791-1798.
  • 2 Tait C, Baglin T, Watson H. et al. Guidelines on the investigation and management of venous thrombosis at unusual sites. Br J Haematol 2012; 159: 28-38.
  • 3 Martinelli I, Sacchi E, Landi G. et al. High risk of cerebral vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Eng J Med 1998; 338: 1793-1797.
  • 4 Madonna P, De Stefano V, Coppola A. et al. G20210A prothrombin gene mutation and other thrombophilic polymorphisms in patients with cerebral vein thrombosis. Stroke 2000; 31: 1787-1788.
  • 5 Tufano A, Guida A, Coppola A. et al. Risk factors and recurrent thrombotic episodes in patients with cerebral vein thrombosis. Blood Transfusion. 2013 Epub ahead of print.
  • 6 Jick H, Slone D, Westerholm B. et al. Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 1969; 01: 539-542.
  • 7 Wautrecht JC, Galle C, Motte S. et al. The role of ABO blood groups in the incidence of deep vein thrombosis. Thromb Haemost 1998; 79: 688-689.
  • 8 Tirado I, Mateo J, Soria JM. et al. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 2005; 93: 468-474.
  • 9 Trégouët DA, Heath S, Saut N. et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 2009; 113: 5298-5303.
  • 10 Germain M, Saut N, Greliche N. et al. Genetics of venous thrombosis: insights from a new genome wide association study. PLoS ONE 2011; 06: e25581.
  • 11 Wu O, Bayoumi N, Vickers MA. et al. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 06: 62-69.
  • 12 Dentali F, Sironi AP, Ageno W. et al. Non-O blood type is the commonest genetic risk factor for VTE: Results from a meta-analysis of the literature. Semin Thromb Hemost 2012; 38: 535-548.
  • 13 Franchini M, Makris M. Non-O blood group: an important genetic risk factor for venous thromboembolism. Blood Transfus. 2012 Epub ahead of print.
  • 14 Koster T, Blann AD, Briet E. et al. Role of clotting factor VIII in eWillebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis. J Thromb Haemost 2006; 04: 2556-2562.
  • 15 Moeller A, Weippert-Kretschmer M, Prinz H. et al. Influence of AB0 blood group on primary haemostasis. Transfusion 2001; 41: 56-60.
  • 16 Spiezia L, Campello E, Bon M. et al. ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia. Blood Transfus. 2012 Epub ahead of print.
  • 17 Cohen W, Castelli C, Alessi M-C. et al. ABO group and von Willebrand factor levels partially explained the incomplete penetrance of congenital thrombophilia. Arterioscler Thromb Vasc Biol 2012; 32: 2021-2028.
  • 18 Miñano A, Ordóñez A, España F. et al. ABO blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Haematologica 2008; 93: 729-734.